跳至主要内容
临床试验/NCT02437981
NCT02437981Enrolling By Invitation不适用

Thai Red Cross AIDS Research Centre (TRC-ARC)

Thai Red Cross AIDS Research Centre1 个研究点 分布在 1 个国家目标入组 20,000 人开始时间: 2014年12月最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
Enrolling By Invitation
入组人数
20,000
试验地点
1
主要终点
Primary outcome measures:

研究概览

简要总结

PrEP-30 is a demonstration project to assess the feasibility of providing oral PrEP to MSM and other individuals at-risk for HIV in Bangkok, Thailand as a service that is funded entirely through user fees. Tenofovir disoproxil fumarate/emtricitabine PrEP is provided part of a combined HIV prevention program that includes risk-reduction counseling, regular HIV testing, and the provision of condoms and lubricants. PrEP-30 is implemented at the Thai Red Cross AIDS Research Centre, at the site of the largest HIV counseling and testing center in Thailand.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age > 18 years
  • HIV test negative
  • Creatinine clearance > 60 ml/min
  • No contraindication or allergy to PrEP medications (TDF/FTC)
  • At least one risk factor for HIV infection within the previous 6 months:
  • sex partner known to be HIV positive
  • works as commercial sex worker
  • use of PEP for sexual exposure
  • injection drug use
  • any STI (syphilis, gonorrhea, chlamydia)
  • > 5 sex partners
  • inconsistent condom use with high-risk partners, including MSM, IDU
  • MSM: any insertive or receptive anal sex without condom
  • Women: any sex without condom with high-risk male partner (MSM, IDU, multiple female partners)
  • Heterosexual men: any sex without condom with high-risk female partner (commercial sex worker, IDU, multiple male partners)

排除标准

  • 未提供

结局指标

主要结局

Primary outcome measures:

时间窗: 12 months

1. Assess the uptake of fee-based oral PrEP by MSM and other at-risk individuals who present for HIV testing or other services. 2. Assess the acceptability, tolerance and safety of oral PrEP. 3. Assess patient satisfaction with oral PrEP delivered through a fee-based system in an HIV testing center. 4. Assess the effectiveness of oral PrEP in a fee-based model. 5. Assess the cost-effectiveness of oral PreP delivered in a fee-based system.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验